
Sign up to save your podcasts
Or


Send us Fan Mail
On today’s episode, we revisit a previously recorded podcast featuring Dr. Hanna and other guests as they discuss the important topic of breast cancer awareness. Breast cancer is the most common cancer among American women, aside from skin cancer. Currently, the average lifetime risk of a woman in the United States developing breast cancer is about 13%, meaning there is a 1 in 8 chance she will develop the disease during her lifetime. Conversely, there is a 7 in 8 chance she will never develop breast cancer.
Breast cancer is also the second leading cause of cancer-related death among women, surpassed only by lung cancer. The likelihood of a woman dying from breast cancer is approximately 1 in 38, or about 2.6%. Encouragingly, breast cancer death rates among women declined by 40% between 1989 and 2016. Since 2007, death rates have remained stable for women younger than 50 while continuing to decrease among older women. These improvements are believed to result from earlier detection through screenings, increased public awareness, and advances in treatment options.
Support the show
By Dr. Steve WellsSend us Fan Mail
On today’s episode, we revisit a previously recorded podcast featuring Dr. Hanna and other guests as they discuss the important topic of breast cancer awareness. Breast cancer is the most common cancer among American women, aside from skin cancer. Currently, the average lifetime risk of a woman in the United States developing breast cancer is about 13%, meaning there is a 1 in 8 chance she will develop the disease during her lifetime. Conversely, there is a 7 in 8 chance she will never develop breast cancer.
Breast cancer is also the second leading cause of cancer-related death among women, surpassed only by lung cancer. The likelihood of a woman dying from breast cancer is approximately 1 in 38, or about 2.6%. Encouragingly, breast cancer death rates among women declined by 40% between 1989 and 2016. Since 2007, death rates have remained stable for women younger than 50 while continuing to decrease among older women. These improvements are believed to result from earlier detection through screenings, increased public awareness, and advances in treatment options.
Support the show